1. BCR‐ABL residues interacting with ponatinib are critical to preserve the tumorigenic potential of the oncoprotein. Issue 3 (2nd December 2013) Authors: Buffa, Pietro; Romano, Chiara; Pandini, Alessandro; Massimino, Michele; Tirrò, Elena; Di Raimondo, Francesco; Manzella, Livia; Fraternali, Franca; Vigneri, Paolo G. Journal: FASEB journal Issue: Volume 28:Issue 3(2014) Page Start: 1221 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗